Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Inflammation and prognosis in colorectal cancer.

Klintrup K, Mäkinen JM, Kauppila S, Väre PO, Melkko J, Tuominen H, Tuppurainen K, Mäkelä J, Karttunen TJ, Mäkinen MJ.

Eur J Cancer. 2005 Nov;41(17):2645-54. Epub 2005 Oct 18.

PMID:
16239109
[PubMed - indexed for MEDLINE]
2.

Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers.

Palmqvist R, Sellberg P, Oberg A, Tavelin B, Rutegård JN, Stenling R.

Br J Cancer. 1999 Feb;79(3-4):577-81.

PMID:
10027333
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

[Prognostic value of the grade of cellular differentiation, of mucus presence and the growth pattern of the invasive margin in colorectal adenocarcinomas Dukes B].

Henrique-Filho C, Bromberg SH, Barreto E, Godoy AC, Mattosinho-França LC.

Arq Gastroenterol. 2004 Jul-Sep;41(3):185-9. Epub 2005 Jan 21. Portuguese.

PMID:
15678204
[PubMed - indexed for MEDLINE]
Free Article
4.

Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.

Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.

Oncology. 2006;70(5):366-77. Epub 2006 Dec 15.

PMID:
17179731
[PubMed - indexed for MEDLINE]
5.

Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue.

Nielsen HJ, Hansen U, Christensen IJ, Reimert CM, Brünner N, Moesgaard F.

J Pathol. 1999 Dec;189(4):487-95.

PMID:
10629548
[PubMed - indexed for MEDLINE]
6.

Stromal myofibroblasts predict disease recurrence for colorectal cancer.

Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.

Clin Cancer Res. 2007 Apr 1;13(7):2082-90.

PMID:
17404090
[PubMed - indexed for MEDLINE]
Free Article
7.

Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer.

Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC.

Eur J Cancer. 2009 Aug;45(12):2138-45. doi: 10.1016/j.ejca.2009.04.011. Epub 2009 May 4.

PMID:
19409772
[PubMed - indexed for MEDLINE]
8.

Profiling markers of prognosis in colorectal cancer.

Lyall MS, Dundas SR, Curran S, Murray GI.

Clin Cancer Res. 2006 Feb 15;12(4):1184-91.

PMID:
16489072
[PubMed - indexed for MEDLINE]
Free Article
9.

Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer.

Canna K, McMillan DC, McKee RF, McNicol AM, Horgan PG, McArdle CS.

Br J Cancer. 2004 May 4;90(9):1707-9.

PMID:
15150596
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The inflammatory response within Dukes' B colorectal cancers: implications for progression of micrometastases and patient survival.

Murphy J, O'Sullivan GC, Lee G, Madden M, Shanahan F, Collins JK, Talbot IC.

Am J Gastroenterol. 2000 Dec;95(12):3607-14.

PMID:
11151900
[PubMed - indexed for MEDLINE]
11.

Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.

Michael-Robinson JM, Pandeya N, Walsh MD, Biemer-Huttmann AE, Eri RD, Buttenshaw RL, Lincoln D, Clouston AD, Jass JR, Radford-Smith GL.

J Pathol. 2006 Feb;208(3):381-7.

PMID:
16315333
[PubMed - indexed for MEDLINE]
12.

Tumor budding as a prognostic marker in stage-III rectal carcinoma.

Choi HJ, Park KJ, Shin JS, Roh MS, Kwon HC, Lee HS.

Int J Colorectal Dis. 2007 Aug;22(8):863-8. Epub 2007 Jan 10.

PMID:
17216219
[PubMed - indexed for MEDLINE]
13.

CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

Laghi L, Bianchi P, Miranda E, Balladore E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A, Santoro A, Mantovani A, Roncalli M, Malesci A.

Lancet Oncol. 2009 Sep;10(9):877-84. doi: 10.1016/S1470-2045(09)70186-X. Epub 2009 Aug 3.

PMID:
19656725
[PubMed - indexed for MEDLINE]
14.

The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer.

Davies M, Arumugam PJ, Shah VI, Watkins A, Roger Morgan A, Carr ND, Beynon J.

Clin Transl Oncol. 2008 Mar;10(3):175-9.

PMID:
18321821
[PubMed - indexed for MEDLINE]
15.

Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.

Zafirellis K, Agrogiannis G, Zachaki A, Gravani K, Karameris A, Kombouras C.

J Surg Res. 2008 Jun 1;147(1):99-107. Epub 2007 Jul 26.

PMID:
17655863
[PubMed - indexed for MEDLINE]
16.

Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer.

Koch M, Kienle P, Kastrati D, Antolovic D, Schmidt J, Herfarth C, von Knebel Doeberitz M, Weitz J.

Int J Cancer. 2006 Jun 15;118(12):3072-7. Erratum in: Int J Cancer. 2006 Nov 1;119(9):2245.

PMID:
16425256
[PubMed - indexed for MEDLINE]
17.

Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer.

Leitch EF, Chakrabarti M, Crozier JE, McKee RF, Anderson JH, Horgan PG, McMillan DC.

Br J Cancer. 2007 Nov 5;97(9):1266-70. Epub 2007 Oct 9.

PMID:
17923866
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.

Jimi S, Hotokezaka M, Eto TA, Hidaka H, Maehara N, Chijiiwa K.

Hepatogastroenterology. 2008 May-Jun;55(84):926-9.

PMID:
18705299
[PubMed - indexed for MEDLINE]
19.

Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.

Miyazaki T, Okada N, Ishibashi K, Ogata K, Ohsawa T, Ishiguro T, Nakada H, Yokoyama M, Matsuki M, Kato H, Kuwano H, Ishida H.

Jpn J Clin Oncol. 2008 Dec;38(12):839-43. doi: 10.1093/jjco/hyn106. Epub 2008 Oct 15.

PMID:
18923001
[PubMed - indexed for MEDLINE]
Free Article
20.

Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma.

Losi L, Ponti G, Gregorio CD, Marino M, Rossi G, Pedroni M, Benatti P, Roncucci L, de Leon MP.

Pathol Res Pract. 2006;202(9):663-70. Epub 2006 Jul 24.

PMID:
16860493
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk